KAŇKOVÁ, Kateřina, Marta KALOUSOVÁ, Miluše HERTLOVÁ, Darja KRUSOVÁ and Tomáš ZIMA. Relationship between circulating levels of soluble RAGE (sRAGE) and genetic variability in the AGER gene in subjects with diabetic nephropathy. In The Maillard Reaction in Food and Medicine. 2006.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Relationship between circulating levels of soluble RAGE (sRAGE) and genetic variability in the AGER gene in subjects with diabetic nephropathy
Name in Czech Vztah mezi hladinami cirkulujícího solubilního RAGE (sRAGE) a genetickou variabilitou v AGER genu u diabetické nefropatie
Authors KAŇKOVÁ, Kateřina (203 Czech Republic, guarantor), Marta KALOUSOVÁ (203 Czech Republic), Miluše HERTLOVÁ (203 Czech Republic), Darja KRUSOVÁ (203 Czech Republic) and Tomáš ZIMA (203 Czech Republic).
Edition The Maillard Reaction in Food and Medicine, 2006.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30202 Endocrinology and metabolism
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14330/06:00015337
Organization unit Faculty of Informatics
Keywords in English diabetic nephropathy; RAGE; polymorphism; sRAGE; renal failure
Tags diabetic nephropathy, polymorphism, RAGE, renal failure, sRAGE
Changed by Changed by: prof. MUDr. Kateřina Kaňková, Ph.D., učo 2524. Changed: 2/4/2010 15:16.
Abstract
RAGE2 haplotype was previously identified as a genetic risk factor for the development and early onset of diabetic nephropathy. Curent study showed that (i) sRAGE significantly differed among subjects bearing variable number of RAGE2 haplotype copies, (ii) was significantly higher in subjects with nephropathy than normoalbuminuric patients and (iii) positively correlated with severity of nephropathy, S-urea, S-creatinine and negatively with glomerular filtration rate (GFR). GFR seems to be principal determinant of the AGE and sRAGE levels.
Abstract (in Czech)
RAGE2 haplotyp byl identifikován jako genetický rizikový faktor časného nástupu diabetické nefropatie. Tato studie prokázala, že (i) sRAGE se signifikantně liší mezi skupinami osob nesoucími variabilní počet kopií RAGE2 haplotypu, (ii) sRAGE je signif. vyšší u osob s nefropatií než normoalbuminurických diabetiků a (iii) pozitivně koreluje s tíhou nefropatie, S-ureou, S-kreatininem a negativně s glomerulární filtrační rychlostí (GFR). GFR je zřejmě hlavní determinanta hladin AGE a sRAGE.
Links
KJB501620601, research and development projectName: Funkční analýza rizikového haplotypu RAGE genu a jeho role v patogenezi hyperglykemií indukovaných změn
Investor: Academy of Sciences of the Czech Republic, Functional analysis of the RAGE gene susceptibility haplotype and its role in the hyperglycemia-driven pathology
MSM0021620807, plan (intention)Name: Metabolické, endokrinní a genetické aspekty prevence, diagnostiky a terapie kardiovaskulárních, cerebrovaskulárních a renovaskulárních onemocnění
PrintDisplayed: 30/4/2024 20:20